Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guillermo Garcia

Showing results (241-250 of 1,188) with videos related to

Pageof 119
Sort By:
Blood Purification|November 30, 2021
Vascular Access and Clinical Outcomes in Underserved Hemodialysis Patients in MexicoPablo Maggiani-Aguilera, Jochen G Raimann, Jonathan S Chávez-Iñiguez, et al.
Annals of Hematology|August 5, 2021
Phase II study of single-agent nivolumab in patients with myelofibrosisIman Abou Dalle, Hagop Kantarjian, Naval Daver, et al.
Free Radical Biology & Medicine|November 14, 2022
Singlet oxygen and radical-mediated mechanisms in the oxidative cellular damage photosensitized by the protease inhibitor simeprevirGuillermo Garcia-Lainez, Meryem El Ouardi, Alejandro Moreno, et al.
Research Square|April 1, 2024
Association between class III obesity and overall survival in previously untreated younger patients with acute myeloid leukemia enrolled on SWOG S1203Mary-Elizabeth Percival, Michelle Zhang, Megan Othus, et al.
International Journal of Molecular Sciences|June 12, 2026
Flavonoid <i>O</i>-Methyltransferases in <i>Eucalyptus</i>-Biosynthesis of Alpinetin via a Methylated Chalcone PrecursorLiyuan Zhu, Guillermo Garcia-Gimenez, John Humphries, et al.
The Journal of Infectious Diseases|July 28, 2011
Fitness and virulence costs of Candida albicans FKS1 hot spot mutations associated with echinocandin resistanceRonen Ben-Ami, Guillermo Garcia-Effron, Russell E Lewis, et al.
Cancer|August 31, 2010
Outcome of therapy-related acute promyelocytic leukemia with or without arsenic trioxide as a component of frontline therapyFarshid Dayyani, Hagop Kantarjian, Susan O'Brien, et al.
Cancer|May 26, 2010
Survival outcomes for clonal evolution in chronic myeloid leukemia patients on second generation tyrosine kinase inhibitor therapyDushyant Verma, Hagop Kantarjian, Jianqin Shan, et al.
Leukemia Research|March 18, 2024
Pracinostat combined with azacitidine in newly diagnosed adult acute myeloid leukemia (AML) patients unfit for standard induction chemotherapy: PRIMULA phase III studyGuillermo Garcia-Manero, Maciej Kazmierczak, Agnieszka Wierzbowska, et al.
Clinical Lymphoma, Myeloma & Leukemia|May 22, 2024
Eosinophilia During Lenalidomide Therapy in Myelodysplastic SyndromeKoji Sasaki, Hagop Kantarjian, Guillermo Montalban-Bravo, et al.
Pageof 119

Showing results (241-250 of 1,188) with videos related to

Sort By:
Pageof 119
Blood Purification|November 30, 2021
Vascular Access and Clinical Outcomes in Underserved Hemodialysis Patients in MexicoPablo Maggiani-Aguilera, Jochen G Raimann, Jonathan S Chávez-Iñiguez, et al.
Annals of Hematology|August 5, 2021
Phase II study of single-agent nivolumab in patients with myelofibrosisIman Abou Dalle, Hagop Kantarjian, Naval Daver, et al.
Free Radical Biology & Medicine|November 14, 2022
Singlet oxygen and radical-mediated mechanisms in the oxidative cellular damage photosensitized by the protease inhibitor simeprevirGuillermo Garcia-Lainez, Meryem El Ouardi, Alejandro Moreno, et al.
Research Square|April 1, 2024
Association between class III obesity and overall survival in previously untreated younger patients with acute myeloid leukemia enrolled on SWOG S1203Mary-Elizabeth Percival, Michelle Zhang, Megan Othus, et al.
International Journal of Molecular Sciences|June 12, 2026
Flavonoid <i>O</i>-Methyltransferases in <i>Eucalyptus</i>-Biosynthesis of Alpinetin via a Methylated Chalcone PrecursorLiyuan Zhu, Guillermo Garcia-Gimenez, John Humphries, et al.
The Journal of Infectious Diseases|July 28, 2011
Fitness and virulence costs of Candida albicans FKS1 hot spot mutations associated with echinocandin resistanceRonen Ben-Ami, Guillermo Garcia-Effron, Russell E Lewis, et al.
Cancer|August 31, 2010
Outcome of therapy-related acute promyelocytic leukemia with or without arsenic trioxide as a component of frontline therapyFarshid Dayyani, Hagop Kantarjian, Susan O'Brien, et al.
Cancer|May 26, 2010
Survival outcomes for clonal evolution in chronic myeloid leukemia patients on second generation tyrosine kinase inhibitor therapyDushyant Verma, Hagop Kantarjian, Jianqin Shan, et al.
Leukemia Research|March 18, 2024
Pracinostat combined with azacitidine in newly diagnosed adult acute myeloid leukemia (AML) patients unfit for standard induction chemotherapy: PRIMULA phase III studyGuillermo Garcia-Manero, Maciej Kazmierczak, Agnieszka Wierzbowska, et al.
Clinical Lymphoma, Myeloma & Leukemia|May 22, 2024
Eosinophilia During Lenalidomide Therapy in Myelodysplastic SyndromeKoji Sasaki, Hagop Kantarjian, Guillermo Montalban-Bravo, et al.
Pageof 119